1. Information and intelligence
Aim
Primary driver
Secondary driver
Concept(s) of change / Improvement Agenda
Measure(s) of change
Cross-cutting themes
To deliver a single suspected cancer pathway where 95% of all patients diagnosed commence 1st definitive treatment <62 days of point of suspicion, by 31st March 2019
Implementing Enabling infrastructure
Point of Suspicion (POS)
Develop Point Of Suspicion (POS) detailed guidance
Point Of Suspicion (POS) guidance produced and available
Person centred care
Information and intelligence
SCP Standard Operating Procedure (SOP) for upgrade to SCP
Develop a Standard Operating Procedure (SOP) for upgrade to SCP
Standard Operating Procedure (SOP) for upgrade to SCP produced and available
Electronical referral systems
Implement electronical referrals across primary and secondary care to trigger start of SCP
% of referrals received electronically by (LHB and by CSG)
Median time from PoS to system to referral/upgrade
Implementation of e Vetting of all referrals
Implement electronic referrals across MDT’s and tertiary centres to expedite time to treatment
% of regional MDT referrals and tertiary treatment referrals made electronically by HB and CSG
Patient tracking systems
Work with HB’s, NWIS and F4C to develop system that can work across primary, secondary and tertiary care to push patient through system and record and report pathway milestones
Existence of tracking systems for all cancer in all HBs
% of patient coverage for electronic tracking system by HB and by CSG
% of complete patient datasets
Reporting of Cancer Waiting Time (CWT) performance
Develop local Business Intelligence dashboards for LHBs and national BI dashboard for CSGs / WCN / WG
LHB / CSG/ other % with access to local/national dashboard
Performance % v key metrics including; Cancer Waiting Time target, conversion, detection etc.
Transforming Whole Pathways
Capacity and Demand Modelling
Support Capacity and Demand (C&D) Modelling work in collaboration with the Delivery Unit (DU)
Agreed framework for C&D work
National and health board level reports sharing findings
Diagnostic pathway < 28days including staging
Develop standardised optimal pathways for each CSG with defined pathway step and reports of component waits
% of CSGs with an agreed optimal pathway by end of March 2018
Performance % v CSG and LHB to developed and agreed pathway
Improved patient experience
Provide easier access for primary and secondary care to diagnostics for ‘suspected cancer’,
Changes in staging data
Suspicion to diagnosis / treatment
LHBs/WCN to establish cancer improvement support teams to deliver cross-pathway work (regional diagnostics, tertiary pathways)
% referrals that are managed as straight to test
Roll out STT protocols
Provide improvement support to MDTs and services such as Radiology / Pathology / Endoscopy
Treatment pathway
<21 days
Develop optimum treatment pathways with agreed target for each treatment by HB and CSG
Develop treatment waiting time reports from DTT to treatment for each CSG and HB
Improve secondary / tertiary pathway flow
% of MDT who has undertaken IQT bronze or equivalent in Pathway Improvement